05 Compliance

Where creatine monohydrate is permitted, and what the file must show

Technical document 05 · Reviewed 2026-11-18 · Creatine Monohydrate

On this page
  1. Three markets, one file structure
  2. European Union: a national supplement route
  3. United States: a dietary supplement, not a drug
  4. United Kingdom: GB and Northern Ireland diverge
  5. The contaminant and impurity table
  6. What the pack may say
  7. The document set behind the lot
  8. Eight checks before the file is signed

Creatine monohydrate is sold as a food-supplement ingredient in the EU, the US and the UK, but the three markets do not apply one rule. The EU classifies it as an “other substance” under national supplement rules rather than as an Annex II vitamin or mineral; the US regulates it as a dietary supplement under DSHEA and the cGMP regulation; the UK has its own supplement regulations and a Great Britain claims register. In all three, the file proves identity, purity, contaminants and manufacturing, and the label claim remains the brand owner's responsibility.

In one line

Creatine monohydrate is a food-supplement ingredient in the EU, US and UK, and the file has to prove the identity, the impurities and the label, not a health claim.

Three markets, one file structure

“Permitted” is not “approved”. None of the three markets grants a pre-market approval for a food-supplement ingredient as it does for a medicine. The brand owner is responsible for the finished product; the supplier's file supports that responsibility with evidence, not permission.

The file has four layers: identity (creatine monohydrate, not another salt or a diluted powder), purity (creatinine and dicyandiamide), contaminants (heavy metals and microbiology) and manufacturing (site, process, allergens, certificates). The label layer is separate and is governed by the market where the pack is sold, not by the country of manufacture.

The positions below are as of this review; the current text of each instrument governs.

European Union: a national supplement route

Directive 2002/46/EC harmonises food supplements, but Annexes I and II cover vitamins, minerals and their permitted forms. Creatine is neither, so it falls to the “other substance” route: Member States may allow it under national rules, subject to general food law and notification where required. Confirm the destination country before the label is printed.

The Commission's novel-food consultation records creatine monohydrate, including a micronized grade, as consumed before 15 May 1997 and therefore not novel. That supports the ingredient; it does not replace national notification or the contaminant and labelling rules.

Four instruments sit around it: Regulation (EC) No 178/2002, Regulation (EU) 2023/915 on contaminants, Regulation (EU) No 1169/2011 on food information and Regulation (EC) No 1924/2006 on claims. Check the current consolidated text; the annexes and the register are amended.

United States: a dietary supplement, not a drug

Creatine monohydrate is a dietary supplement under DSHEA. The manufacturer follows the cGMP rule in 21 CFR 111, and the label carries a Supplement Facts panel with the amount per serving and the other ingredients.

Creatine has a long US marketing history, which normally supports a pre-1994 status, but a new source, process or form can still raise an NDI question; the supplier's file should answer it. FDA does not approve a supplement or its label before sale; the responsible firm does.

A structure/function statement is allowed if it is truthful, not misleading and carries the required disclaimer. A disease-related statement is not.

United Kingdom: GB and Northern Ireland diverge

Great Britain applies the Food Supplements (England) Regulations 2003 and the equivalents in Scotland and Wales, with the retained food-information and claims rules. A food supplement must be labelled as such, and a claim must be on the Great Britain register and used under its conditions. Northern Ireland continues to apply the EU regime, so a pack for Belfast and a pack for Manchester can need different wording. The practical check is the destination: GB, NI, or both.

The contaminant and impurity table

The catalog limits are release limits, not a substitute for the destination market's legal limit: the stricter figure applies, and where the law is silent the specification sets its own. The batch COA should report the result and the method for each line, not only “conforms”.

Catalog release limits · creatine monohydrate
ParameterCatalog limitNote
Lead≤3 mg/kgEU supplement maximum: 3.0 mg/kg
Arsenic≤2 mg/kgNo harmonised EU maximum; the specification sets the figure
Cadmium≤1 mg/kgEU supplement maximum: 1.0 mg/kg
Mercury≤0.1 mg/kgEU supplement maximum: 0.1 mg/kg
Creatinine≤100 ppmDegradation product; purity marker
Dicyandiamide≤50 ppmProcess impurity, cyanamide route
Loss on drying≤12.0%Water of crystallisation; high by design
Residue on ignition≤0.1%Inorganic residue; salt or desalting marker
MicrobiologyAPC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absentRelease panel

What the pack may say

The EU and GB registers contain a creatine claim with narrow conditions on daily intake and audience. This page does not reproduce it and does not rely on it. A claim authorised in one market is not automatically valid in another, and an authorised claim used outside its conditions is an unauthorised claim.

The US route is different: a structure/function statement can be used without pre-approval, with the disclaimer, while a disease-related statement cannot. In every market the ingredient name is not a claim: “creatine monohydrate” describes the material, not an effect. A claim lifted from a supplier's marketing sheet, or a “free from” statement that implies an effect, is still a label claim and belongs to the brand owner's review.

The document set behind the lot

Documents that support a creatine monohydrate lot
DocumentWhat it provesIssued by
Batch COAIdentity, assay, impurities, LOD, mesh and contaminants for that lotManufacturer's QC
Technical data sheetCatalog specification, solubility, application and packSupplier
Safety data sheetHazards, handling and transport classificationSupplier
SpecificationThe agreed release limits and methodsSupplier and buyer
Allergen statementAllergen presence or absence, and the basisManufacturer
GMO and non-GMO statementStatus of the raw materials and the processManufacturer
BSE/TSE statementAbsence of animal-derived materialManufacturer
Manufacturing flow and originSite, route and traceabilityManufacturer
Certification and audit reportsFood-safety system and scopeCertification body

A folder of logos is not a file. Each document should be current, scoped to the site and the product; a certificate for another grade or site does not support this lot.

Eight checks before the file is signed

  1. Is the material named as creatine monohydrate, with CAS 6020-87-7 and the formula C₄H₉N₃O₂·H₂O?
  2. Does the COA show the assay basis, creatinine, dicyandiamide, LOD, residue on ignition and mesh?
  3. Do the contaminant results meet the destination market's current limits, with methods named?
  4. Is the manufacturing site, country of origin and process route identified?
  5. Are the certificates current, in scope and issued for this product?
  6. Does the label use the market's term — “food supplement” in the EU and UK, “dietary supplement” in the US?
  7. Is every claim authorised and used under its conditions, or a structure/function statement with the disclaimer?
  8. Is a retained sample held, and is there a route for a non-conforming lot?

Start with the product page for the catalog figures, then the COA page for the release lines, the identity page for the evidence, the stability page for storage wording, and the EU note, UK note and US note for market rules.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation